Is Tesamorelin legal in United States?

Tesamorelin is among the peptides readers most often ask about in United States. This page focuses on the regulatory reality there, not on how to obtain or use it, because that is where reliable, localized information is hardest to find.

In the United States, Tesamorelin is an FDA-approved, prescription-only medicine, marketed as Egrifta for HIV-associated lipodystrophy (originally approved in 2010), and regulated by FDA (U.S. Food and Drug Administration).

As an approved prescription medicine, Tesamorelin is supplied through US pharmacies on prescription. Importing unapproved or foreign versions is generally not permitted. Holding Tesamorelin on a valid US prescription is lawful; obtaining or holding it without one is not.

Selling or supplying Tesamorelin without the required authorisation is an offence in United States. FDA (U.S. Food and Drug Administration) sets out the applicable sanctions; we do not reproduce specific figures here because they change. Confirm the current penalties with the regulator. This page reflects our reading of the position as of the last-verified date; regulations change, so confirm with FDA (U.S. Food and Drug Administration) before making any decision.